STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2024 Measures to enhance earnings show effect; at 8.4%, adjusted EBIT margin for 9M/2024 almost matches previous year’s level (9M/2023: 8.6%) despite negative scale effects Sales on a constant-currency basis -6.0% to € 176.3 million in 9M/2024 (9M/2023: € 187.7 million) Significantly improved sal [ … ]

STRATEC POSTS RESULTS FOR FIRST HALF OF 2024 Considerably improved business dynamics in second quarter (sales Q2/2024: constant currency +5.3%); sales in H1/2024: constant currency -4.9% to € 119.1 million (H1/2023: € 125.0 million) Adjusted EBIT margin of 9.6% in Q2/2024 (Q2/2023: 4.9%); adjusted EBIT margin in H1/2024 improves by 260 basis poi [ … ]

STRATEC REPORTS CHANGES IN FINANCE DIVISION Birkenfeld, July 30, 2024 STRATEC SE, a leading manufacturer of automation solutions for partners in clinical diagnostics and life sciences, is reporting a change in the composition of its Board of Management. In agreement with the company, Dr. Robert Siegle, a member of the Board of Management of STR [ … ]

STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS Birkenfeld, May 17, 2024 Shareholders at today’s Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard, SDAX) approved all agenda items submitted for resolution with the necessary majority in each case. As proposed, STRATEC will enable its  [ … ]

STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 Subdued start to financial year as expected, but noticeable revival apparent in market and very strong sales growth expected for second quarter of 2024 Consolidated sales Q1/2024 -15.7% at constant currency to € 50.9 million (Q1/2023: € 60.5 million) Efficiency measures and structural changes taki [ … ]

STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR Consolidated sales in 2023 -3.8% at constant currency to € 261.9 million (2022: € 274.6 million); Constant-currency growth of 12.9% in Q4/2023 Adjusted EBIT margin of 10.3% (2022: 16.4%) within guidance corridor New product launch and newly concluded development cooperations with partners 2024 gu [ … ]

STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR Consolidated sales in 2023 -3.8% at constant currency to € 261.9 million (2022: € 274.6 million); Constant-currency growth of 12.9% in Q4/2023 Adjusted EBIT margin of 10.3% (2022: 16.4%) within guidance corridor New product launch and newly concluded development cooperations with partners 2024 gu [ … ]